No Detail Found!

Outcomes of Empyema Management with Intrapleural tPA and DNase

Author(s)
Madhavi Cherukula Internal Medicine Residency Program and Division of Pulmonary and Critical Care at the Department of Internal Medicine, University of Tennessee College of Medicine at Chattanooga,Chattanooga, Tennessee,USA
Orlando Turner Internal Medicine Residency Program and Division of Pulmonary and Critical Care at the Department of Internal Medicine, University of Tennessee College of Medicine at Chattanooga,Chattanooga, Tennessee,USA
Amirtha Dileepan Internal Medicine Residency Program and Division of Pulmonary and Critical Care at the Department of Internal Medicine, University of Tennessee College of Medicine at Chattanooga,Chattanooga, Tennessee,USA
Sibaji Shome Internal Medicine Residency Program and Division of Pulmonary and Critical Care at the Department of Internal Medicine, University of Tennessee College of Medicine at Chattanooga,Chattanooga, Tennessee,USA
Abstract
BACKGROUND: Parapneumonic effusions and empyema are side effects of pneumonia that cause significant morbidity and mortality. Current guidelines recommend drainage of these effusions with tube thoracostomy or surgical debridement in addition to systemic antibiotics. This case series examines the technique to maximize drainage of complicated parapneumonic effusions (cPPE) through tube thoracostomy by instilling tissue plasminogen activator (tPA)/ deoxyribonuclease (DNase) tPA and DNase into the pleural cavity in a community hospital setting. METHODS: We retrospectively reviewed all patients admitted to Erlanger hospital in Chattanooga from Jan 2010 to April 2015 who presented with cPPE and were treated with intrapleural medications to increase drainage. Data was collected, tabulated, and summarized with mean (standard deviation) or frequencies as appropriate. RESULTS: We reviewed 9 cases; 6 women and 3 men (age range: 44 to 86 years). In total, there were 6 patients with empyema and 3 patients with cPPE. The decrease in size of the pleural effusion was seen qualitatively on chest X-ray, and quantitatively, the output from the chest tube after the tPA and DNase treatment. The decrease in chest tube output ranged from 24 L. Of the 6 patients who had empyema, 4 required surgical lung decortication. The 3 patients with cPPE were managed with medical therapy and had adequate clinical improvement. The average hospital stay was 16.1 days. CONCLUSION: In this small series, the intrapleural tPA and DNase was effective in reducing the size of pleural effusion as well as reducing the rate of surgical consultation.
Publication Details
Page(s) 104-106
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 6, Issue: 4, Year: 2016

Request the full text from PASTIC

Keywords
Deoxyribonuclease, pneumonia, Empyema, Parapneumonic Effusions, Tissue plasminogen activator
References
Ahmed AH,Yacoub TE .2010 .Intrapleural therapy in management of complicated parapneumonic effusions and empyema. Clinical pharmacology: advances and applications, 2 : 213-21.
Chest .2000 .. , 118(4) : 1158-71.
Maskell NA,Davies CW,Nunn AJ,Hedley EL,Gleeson FV,Miller R .2005 .Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med, 352(9) : 865-74.
Rahman NM,Maskell NA,West A,Teoh R,Arnold A,Mackinlay C .2011 .Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med, 365(6) : 518-26.
Sogaard M,Nielsen RB,Norgaard M,Kornum JB,Schonheyder HC,Thomsen RW . .Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study. , : .
Chest .2014 .. , 145(1) : 189-92.
Bender MT,Ferraris VA,Saha SP .2015 .Modern management of thoracic empyema. Southern Medical Journal, 108(1) : 58-62.
.2014 .Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. The Clinical Respiratory Journal, 8(3) : 281-91.
0

Citations

0

Downloads

10

Views